Man Group
MIRM icon

Man Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Man Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35M Buy
+37,183
New +$3.73M 0.01% 1214
2026
Q1 		– Sell
-6,841
Closed -$540K – 2504
2025
Q4 		$540K Buy
6,841
+2,881
+73% +$207K ﹤0.01% 1872
2025
Q3 		$290K Sell
3,960
-15,847
-80% -$1.01M ﹤0.01% 2015
2025
Q2 		$1.01M Sell
19,807
-11,818
-37% -$526K ﹤0.01% 1629
2025
Q1 		$1.42M Buy
31,625
+24,636
+352% +$1.16M ﹤0.01% 1486
2024
Q4 		$289K Buy
+6,989
New +$291K ﹤0.01% 1802

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's MIRM Position: Q2 2026 in Review

Man Group opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 37,183 shares worth $4.35M. The stake represents 0.01% of the portfolio and ranks #1214 among its holdings. This is a return to the name: Man Group previously reported a position in MIRM as recently as Q4 2025.

Man Group first reported a position in MIRM in Q4 2024 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Man Group held 37,183 shares of Mirum Pharmaceuticals worth $4.35M as of Q2 2026.
  • Mirum Pharmaceuticals was a new Man Group position in Q2 2026.
  • Mirum Pharmaceuticals made up 0.01% of Man Group's portfolio in Q2 2026, its #1214 holding.
  • Man Group first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.